Other OTC • Healthcare • Medical - Devices • US • USD
Talis Biomedical Corporation (TLIS) has a consensus analyst rating of Sell, based on 4 analysts covering the stock. Of those, 0 recommend buying, 1 recommend holding, and 3 recommend selling.
No price target data available.
Be the first to know when stocks drop below their intrinsic value.
